NYSE:MYOV
Myovant Sciences Ltd.
- Stock
Last Close
26.99
09/03 21:01
Market Cap
2.62B
Beta: 2.15
Volume Today
2.26M
Avg: 1.09M
PE Ratio
−14.22
PFCF: −9.69
Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|---|
net income | -83.44M - | -143.25M 71.69% | -273.55M 90.95% | -288.99M 5.64% | -255.13M 11.71% | -205.98M 19.27% | |
depreciation and amortization | 61K - | 243K 298.36% | 438K 80.25% | 1.76M 302.97% | 2.48M 40.45% | 3.07M 23.92% | |
deferred income tax | -208K - | 208K 200% | 4.85M - | -16.18M 433.46% | |||
stock based compensation | 8.72M - | 11.58M 32.88% | 18.70M 61.41% | 40.25M 115.29% | 53.68M 33.35% | 38.93M 27.48% | |
change in working capital | 15.67M - | 13.63M 13.04% | 27.01M 98.19% | 21.44M 20.61% | 584.61M 2,626.22% | -107.00M 118.30% | |
accounts receivables | -3.57M - | -19.73M 452.55% | |||||
inventory | -2.61M - | -4.97M 90.46% | |||||
accounts payables | 3.33M - | 1.25M 62.48% | 6.44M 415.69% | 4.32M 33.01% | 2.46M 43.06% | -5.62M 328.61% | |
other working capital | 12.34M - | 12.38M 0.29% | 20.57M 66.16% | 17.13M 16.72% | 588.34M 3,334.73% | -76.69M 113.03% | |
other non cash items | 40.98M - | 338K 99.18% | 3.32M 881.95% | -494K 114.88% | 1.17M 337.25% | 2.42M 106.74% | |
net cash provided by operating activities | -18.21M - | -117.25M 543.73% | -224.09M 91.11% | -221.17M 1.30% | 370.63M 267.57% | -268.56M 172.46% | |
investments in property plant and equipment | -967K - | -604K 37.54% | -1.24M 104.64% | -1.10M 11.08% | -1.77M 61.33% | -974K 45.06% | |
acquisitions net | |||||||
purchases of investments | -32.08M - | -63.82M 98.98% | -118.75M 86.06% | ||||
sales maturities of investments | 29.24M - | 56.39M 92.84% | 101.70M 80.36% | ||||
other investing activites | |||||||
net cash used for investing activites | -967K - | -604K 37.54% | -1.24M 104.64% | -3.94M 218.37% | -9.21M 134.08% | -18.02M 95.66% | |
debt repayment | -105.42M - | ||||||
common stock issued | 202.28M - | 1.86M 99.08% | 218.93M 11,689.18% | 137.00M 37.42% | |||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | -2.25M - | 43.79M 2,041.82% | 54.97M 25.55% | 114.34M 107.99% | 238.04M 108.19% | 25.91M 89.12% | |
net cash used provided by financing activities | 200.02M - | 45.65M 77.18% | 273.90M 500.06% | 145.93M 46.72% | 238.04M 63.13% | 25.91M 89.12% | |
effect of forex changes on cash | |||||||
net change in cash | 180.84M - | -72.21M 139.93% | 48.58M 167.27% | -79.18M 263.01% | 599.46M 857.08% | -260.68M 143.48% | |
cash at beginning of period | 180.84M - | 108.62M 39.93% | 157.20M 44.72% | 78.02M 50.37% | 677.48M 768.36% | ||
cash at end of period | 180.84M - | 108.62M 39.93% | 157.20M 44.72% | 78.02M 50.37% | 677.48M 768.36% | 416.80M 38.48% | |
operating cash flow | -18.21M - | -117.25M 543.73% | -224.09M 91.11% | -221.17M 1.30% | 370.63M 267.57% | -268.56M 172.46% | |
capital expenditure | -967K - | -604K 37.54% | -1.24M 104.64% | -1.10M 11.08% | -1.77M 61.33% | -974K 45.06% | |
free cash flow | -19.18M - | -117.86M 514.42% | -225.32M 91.18% | -222.27M 1.35% | 368.86M 265.95% | -269.53M 173.07% |
All numbers in USD (except ratios and percentages)